Previous Close | 67.58 |
Open | 66.60 |
Bid | 66.60 x 30000 |
Ask | 67.68 x 30000 |
Day's Range | 66.60 - 66.60 |
52 Week Range | 45.76 - 68.54 |
Volume | |
Avg. Volume | 8 |
Market Cap | 47.361B |
Beta (5Y Monthly) | 1.03 |
PE Ratio (TTM) | 25.04 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.02 (3.00%) |
Ex-Dividend Date | May 06, 2024 |
1y Target Est | N/A |
Insurance giant MetLife rebounded late last year and is putting up strong sales and profit numbers. Additionally, MetLife stock is up 50% over the past year and just below a fresh buy point. The upgraded 82 RS Rating means that MetLife stock topped 82% of all stocks for price performance this past year.
The decent earnings reports have helped the sector to survive the market rout seen last month.
MetLife ( NYSE:MET ) First Quarter 2024 Results Key Financial Results Revenue: US$16.1b (up 4.3% from 1Q 2023). Net...